期刊
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
卷 71, 期 6, 页码 654-667出版社
ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2017.11.067
关键词
cardiac function; cell signaling; hypertrophy; metabolism
资金
- European Union [CardioNeT-ITN-289600, CardioNext-608027, Meet-ITN-317433, UE0/MCA1108]
- Spanish Ministry of Economy and Competitiveness [SAF2015-65722-R, SAF2012-31451, SAF2015-71521-REDC, BFU2013-50448, SAF2012-32776, RyC-2011-07826, BIO2012-37926, BIO2015-67580-P]
- Spanish Carlos III Institute of Health [CPII14/00027, RD12/0042/066]
- Regional Government of Madrid [2010-BMD-2321, 2011-BMD-2402]
- FIS-ISCIII [PRB2-IPT13/0001, RD12/0042/0056-RIC-RETICS]
- Plan Estatal de IthornDthornI -European Regional Development Fund (FEDER) A way of making Europe, Spain
- Spanish Ministry of Economy and Competitiveness
- Pro-CNIC Foundation
- Severo Ochoa Center of Excellence (MINECO) [SEV-2015-0505]
BACKGROUND In response to pressure overload, the heart develops ventricular hypertrophy that progressively decompensates and leads to heart failure. This pathological hypertrophy is mediated, among others, by the phosphatase calcineurin and is characterized by metabolic changes that impair energy production by mitochondria. OBJECTIVES The authors aimed to determine the role of the calcineurin splicing variant CnA beta 1 in the context of cardiac hypertrophy and its mechanism of action. METHODS Transgenic mice overexpressing CnAb1 specifically in cardiomyocytes and mice lacking the unique C-terminal domain in CnA beta 1 (CnA beta 1(Delta i12) mice) were used. Pressure overload hypertrophy was induced by transaortic constriction. Cardiac function was measured by echocardiography. Mice were characterized using various molecular analyses. RESULTS In contrast to other calcineurin isoforms, the authors show here that cardiac-specific overexpression of CnA beta 1 in transgenic mice reduces cardiac hypertrophy and improves cardiac function. This effect is mediated by activation of serine and one-carbon metabolism, and the production of antioxidant mediators that prevent mitochondrial protein oxidation and preserve ATP production. The induction of enzymes involved in this metabolic pathway by CnAb1 is dependent on mTOR activity. Inhibition of serine and one-carbon metabolism blocks the beneficial effects of CnA beta 1. CnA beta 1(Delta i12) mice show increased cardiac hypertrophy and declined contractility. CONCLUSIONS The metabolic reprogramming induced by CnAb1 redefines the role of calcineurin in the heart and shows for the first time that activation of the serine and one-carbon pathway has beneficial effects on cardiac hypertrophy and function, paving the way for new therapeutic approaches. (J Am Coll Cardiol 2018; 71: 654-67) (C) 2018 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY-NC-ND license (http://creativecommons. org/licenses/by-nc-nd/4.0/).
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据